NVX vs. STEM, ULBI, GWH, ELVA, CBAT, DFLI, SES, IMMR, PRCH, and RDVT
Should you be buying NOVONIX stock or one of its competitors? The main competitors of NOVONIX include Stem (STEM), Ultralife (ULBI), ESS Tech (GWH), Electrovaya (ELVA), CBAK Energy Technology (CBAT), Dragonfly Energy (DFLI), SES AI (SES), Immersion (IMMR), Porch Group (PRCH), and Red Violet (RDVT). These companies are all part of the "computer and technology" sector.
Stem (NYSE:STEM) and NOVONIX (NASDAQ:NVX) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.
In the previous week, Stem and Stem both had 1 articles in the media. NOVONIX's average media sentiment score of 1.00 beat Stem's score of 0.33 indicating that Stem is being referred to more favorably in the media.
Stem received 28 more outperform votes than NOVONIX when rated by MarketBeat users.
Stem has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, NOVONIX has a beta of 3.16, suggesting that its stock price is 216% more volatile than the S&P 500.
NOVONIX has lower revenue, but higher earnings than Stem.
61.6% of Stem shares are held by institutional investors. Comparatively, 0.1% of NOVONIX shares are held by institutional investors. 10.2% of Stem shares are held by insiders. Comparatively, 23.7% of NOVONIX shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
NOVONIX has a net margin of 0.00% compared to NOVONIX's net margin of -40.03%. Stem's return on equity of 0.00% beat NOVONIX's return on equity.
Stem presently has a consensus price target of $4.77, suggesting a potential upside of 264.36%. Given NOVONIX's higher probable upside, analysts plainly believe Stem is more favorable than NOVONIX.
Summary
NOVONIX beats Stem on 7 of the 13 factors compared between the two stocks.
Get NOVONIX News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
